Orchestra BioMed Holdings OBIO Cash Flow Statement (2021-2026)

NASDAQ OBIO
$5.07 +0.33 (+6.96%)
As of: Sep 4, 2026 · 3:15 PM EDT
Reported Financials

Orchestra BioMed Holdings Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Orchestra BioMed Holdings reported cash from operations of -$19.33M and free cash flow of -$19.59M for the quarter ended Jun 2026, down 24.5% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.09M-0.09M-5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M-24.12M
Share-based CompensationStock Comp.
0.07M0.14M2.19M0.86M5.20M6.60M5.20M0.92M5.20M11.60M10.70M2.90M5.74M8.30M8.60M2.75M8.37M9.90M
Gains from Investment SecuritiesGains Investment
0.14M1.01M-0.04M0.23M0.29M
Cash from OperationsCash from Ops.
-0.13M-0.03M-5.32M-7.96M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M-2.27M-22.17M-19.33M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.13M0.14M0.15M0.18M1.06M1.06M1.06M0.64M0.59M0.33M0.36M0.23M0.15M0.15M0.19M0.32M0.16M0.32M
Amortization of Deferred ChargesAmort. Deferred Charges
0.06M0.04M0.04M0.04M0.04M0.04M0.04M0.00M0.05M0.05M0.06M0.06M0.06M0.07M
Depreciation & Amortization (CF)Dep. & Amort.
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.09M0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M-0.00M-0.01M-0.03M0.04M-0.01M-0.03M
Change in InventoryChange Inventory
-0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.04M0.16M-0.06M-0.04M0.05M0.18M-0.06M-0.03M-0.03M
Change in Account PayablesChange Payables
-0.02M-267.000.10M0.07M0.11M0.10M
Change in Accured ExpensesChange Accured Exp.
0.03M0.03M0.20M0.47M1.62M1.06M-1.79M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M0.57M-3.06M-0.25M
Other Working Capital ChangesOther WC Changes
-0.72M-0.23M-0.99M-0.93M-1.02M-0.73M-0.27M-0.09M-0.50M-0.63M-0.80M-0.08M-0.73M-0.67M-0.72M-13.31M
Investing Activities
Capital ExpendituresCapex
0.05M0.27M0.22M0.05M0.04M0.03M0.02M-0.00M0.11M0.01M0.07M0.11M0.11M0.03M0.31M0.03M0.18M0.25M
Change in Acquisitions & DivestmentsChange Acquisitions
51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M7.95M18.89M19.90M
Cash from Investing ActivitiesCash from Investing
-0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M-17.71M10.32M-23.31M
Financing Activities
Other financing activitiesOther financing
0.07M0.04M0.00M56.81M0.02M0.17M0.05M0.09M0.03M0.01M
Cash from Financing ActivitiesCash from Financing
24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M12.66M5.53M34.75M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.04M1.09M0.06M1.45M0.12M1.82M1.33M
Additional items
Change in Cash
-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.89M
Free Cash FlowFCF
-0.13M-0.03M-5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.22M-10.21M-13.77M-13.64M-16.73M-15.56M-14.86M-2.30M-22.35M-19.59M
Net Cash FlowNCF
-0.13M-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.89M